Abrysvo, which is now the first maternal RSV vaccine to be prequalified by the organisation, aims to prevent RSV-associated ...

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical ...

GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.8 at the end of 2024 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...

Shots will be available from April 7 to June 30, and will be administered by “participating pharmacies,” the release read.

Moderna has secured FDA approval for its respiratory syncytial virus (RSV ... both GSK and Pfizer’s products. There’s still one more step before Moderna’s vaccine can take on Arexvy and ...

BSI’s goal is to make QS-21 accessible to a wider range of vaccines and populations, particularly in low-income countries.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

American Depositary Receipts (ADR) are US-listed securities that represent shares in foreign companies, allowing American investors to gain exposure to international equities without dealing with ...

Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...

Strongrevenueperformance,includingapproximately$1.9millionmilestoneandlicenserevenuerecognizedin2024Up to $7.5 million in grants awarded from ...

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024Up to $7.5 million in grants awarded from CEPI and Gates Foundation intended to acceler ...